Manufacturer And Supplier 99% Crisaborole Powder CAS Number 906673-24-3 For Eczema

50 grams
MOQ
Negotiable
Price
Manufacturer And Supplier 99% Crisaborole Powder CAS Number 906673-24-3 For Eczema
Features Gallery Product Description Chat Now
Features
Specifications
Grade: Pharmaceutcial Grade
Function: Pharmaceuticals
CAS: 906673-24-3
Purity: 99%
Shelf Life: 2 Years
Test Method: HPLC UV
Storage: Cool Dry Place
Shipping Method: Air(UPS, FedEx, TNT, EMS) Or Sea
Sample: Available
MF: C14H10BNO3
MW: 251.045
Place Of Origin: CN
Service: Professional & Rich Experience
Export Market: Global
Highlight:

Eczema Crisaborole Powder

,

99% Crisaborole Powder

,

CAS Number 906673-24-3 Crisaborole Powder

Basic Infomation
Payment & Shipping Terms
Packaging Details: 1kg/bag
Delivery Time: 2-3 days
Payment Terms: D/A, D/P, L/C, T/T, Western Union, MoneyGram
Supply Ability: 100000 kg per month
Product Description
Manufacturer And Supplier 99% Crisaborole Powder CAS Number 906673-24-3 For Eczema
Crisaborole powder is a topical medication primarily used to treat mild to moderate atopic dermatitis, commonly known as eczema. It is a phosphodiesterase-4 (PDE-4) inhibitor that works by reducing inflammation and itching associated with the condition.
Crisaborole is typically applied directly to affected areas of the skin and is favored for its non-steroidal formulation, making it suitable for patients who prefer to avoid corticosteroids. It is generally well-tolerated, with few systemic side effects, and is especially useful for long-term management of eczema in both adults and children.
Item name Crisaborole
CAS No. 906673-24-3
Purity 99%
Package Aluminum Bag; Drums
Shipment DHL, FedEx, TNT, UPS, Post
Payment Term T/T, Western Union, L/C
Storage Common storage 2-8ºC, long time storage -20ºC
Shelf life 2 years
Function and Application
Crisaborole is a phosphodiesterase 4 (PDE-4) inhibitor, although its specific mechanism of action in atopic dermatitis is not known.
  • In the US, crisaborole is indicated for topical treatment of mild to moderate atopic dermatitis in people three months of age and older.
  • In the EU, crisaborole is indicated for treatment of mild to moderate atopic dermatitis in people two years of age and older with ≤ 40% body surface area (BSA) affected.
Manufacturer And Supplier 99% Crisaborole Powder CAS Number 906673-24-3 For Eczema 0
Recommended Products
Get in touch with us
Contact Person : Nancylee
Tel : +86 15508667508
Characters Remaining(20/3000)